Insider filing · ADMA
Lawrence P. Guiheen
Director
profile →
ADMA Biologics, Inc.
ADMA · Healthcare · 23 filings in 24 months
ticker →
Lawrence P. Guiheen sold $419K of ADMA Biologics (ADMA)
Executed Jun 9 2025, disclosed Jun 11 2025, 2 days later.
Value, as filed
$419K
20,000 sh × $20.96
Executed
Jun 9 2025
the trade date, as filed
Disclosed
Jun 11 2025
2 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
LGLawrence P. Guiheen (Director) filed 2 Form 4 reports in the past 24 months (0 purchases, 2 sales), most often in ADMA Biologics, Inc. (ADMA). The largest single filing was $419K of ADMA (20,000 sh × $20.96, as filed), executed Jun 9 2025.
The name
ADMAHealthcare · ADMA Biologics, Inc., a biopharmaceutical company, develops, manufactures, and markets specialty plasma-derived biologics for the treatment…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Lawrence P. Guiheen in ADMA
ADMASALE
ADMA Biologics, Inc.
$158K7,779 sh × $20.32
Exec May 21 2025
Filed May 23 2025 · 5:30 PM ET